G
GlaxoSmithKline Pharmaceuticals
GLAXO Share Price
Healthcare2,485.90
as on 09 Mar 2026 at 10:58
Market Cap
₹42,113 Cr
PE Ratio
41.70
ROCE
57.25%
GLAXO Fundamentals
Company Valuation
Market Cap (₹ Cr.)
42,113
PE Ratio
41.70
PB Ratio
24.93
Dividend Yield
2.15%
ROE
47.54%
ROCE
57.25%
Book Value (₹)
100.80
Face Value (₹)
10.00
Share Holding Pattern
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|
| Promoters | 75.00% | 75.00% | 75.00% | 75.00% | 75.00% |
| Domestic Institutional Investors (DII) | 7.30% | 7.79% | 7.70% | 7.75% | 7.70% |
| Foreign Institutional Investors (FII) | 4.50% | 4.52% | 4.89% | 4.80% | 4.64% |
| Public Investors | 10.96% | 10.60% | 10.32% | 10.34% | 10.36% |
| Government | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Promoters
Domestic Institutional Investors (DII)
Foreign Institutional Investors (FII)
Public Investors
Government
GLAXO Investment Returns
Short Term
1 Week
1 Month
3 Months
6 Months
9 Months
Long Term
1 Year
2 Years
3 Years
4 Years
5 Years
- In Short Term
- In Long term
1 Week
1 Month
3 Months
6 Months
9 Months
Create Wealth in Longterm with Weekly and Monthly SIP in Stocks.
Stock & Sector Information
Sector
Healthcare
Sub Sector
Pharmaceuticals
Company Classification
Midcap
BSE Scrip Code
500660
NSE Scrip Name
GLAXO
ISIN
INE159A01016



